| payload |
{"created_at":"2026-04-21T03:09:54.871 {"created_at":"2026-04-21T03:09:54.871544+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:f72f6b4a749e4b0f","evidence_event_ids":["evt_10a1e530afe4"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000009.txt","as_of":"2026-04-21T03:09:54.871544+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000009.txt","company":"SCYNEXIS INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000009.txt","article_chars":2728,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_e2298ca0ac99c992","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000009.txt","content_type":"text/plain","enriched_at":"2026-04-21T10:43:06.848149+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"8-K","final_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000009.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000009.txt","source_event_id":"evt_10a1e530afe4","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"afd635287f03325c","kind":"sec_filing","published_at":"20260420","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-16","2026 annual meeting of stockholders","2026 Annual Meeting"],"entities":[{"asset_class":"equity","name":"SCYNEXIS, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"person","name":"Steven C. Gilman","relevance":"high","symbol":"","type":"person"},{"asset_class":"organization","name":"Board of Directors of SCYNEXIS, Inc.","relevance":"medium","symbol":"","type":"organization"},{"asset_class":"committee","name":"Compensation Committee","relevance":"medium","symbol":"","type":"committee"},{"asset_class":"committee","name":"Nominating and Corporate Governance Committee","relevance":"medium","symbol":"","type":"committee"}],"event_type":"other","information_gaps":["No additional 8-K items beyond Item 5.02 are disclosed in the provided text (material_items list is empty).","No details are provided about who will replace Dr. Gilman or whether any director election outcomes are included.","No stock ticker/symbol for SCYNEXIS is provided in the text, so no standardized symbol can be included."],"key_facts":["Form 8-K filed by SCYNEXIS, Inc. (CURRENT REPORT).","On April 16, 2026, Steven C. Gilman notified the company of his intent to retire as a member of the Board and not stand for reelection at the Company\u2019s 2026 annual meeting of stockholders.","Dr. Gilman\u2019s term as a director will end when his current term expires at the 2026 annual meeting.","Dr. Gilman will remain as Chair of the Compensation Committee and a member of the Nominating and Corporate Governance Committee until the conclusion of the 2026 annual meeting.","The filing states Dr. Gilman\u2019s resignation was not the result of any disagreement with the company on matters related to operations, policies, practices, strategy, or management/board."],"numeric_claims":[{"label":"Notification date","value":"2026-04-16"},{"label":"Filing date (SEC filing timestamp provided)","value":"2026-04-21T03:09:54.871544+00:00"}],"primary_claim":"Steven C. Gilman notified SCYNEXIS, Inc. on April 16, 2026 of his intent to retire from the board and not stand for reelection at the 2026 annual meeting, with his term ending at that meeting.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"SCYNEXIS, Inc. filed a Form 8-K reporting that Steven C. Gilman notified the company of his intent to retire from the board and not stand for reelection at the 2026 annual meeting. His director term will end when his current term expires at that meeting, and he will continue committee roles until the meeting concludes.","topics":["SEC filing","Form 8-K","director retirement","board committee roles","2026 annual meeting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 SCYNEXIS INC \u00b7 Filed 20260420","ticker":"SCYX","tickers":["SCYX"],"title":"SCYX filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1178253/0001178253-26-000009.txt"}}... |